Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 4, 1998, Pages 483-487

  Vrioni, G ^a   Nauciel, C ^a   Kerharo, G ^a   Matsiota Bernard, P ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; RIFABUTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; FEMALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM GENAVENSE; NONHUMAN; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; RIFABUTIN; SPLEEN;

EID: 0031687626     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.4.483     Document Type: Article

References (21)

1. Bessesen, M. T., Shlay, J., Stone-Venohr, B., Cohn, D. L. & Reves, R. R. (1993). Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS 7, 1357-61.
2. Böttger, E. C., Teske, A., Kirschner, P., Bost, S., Chang, H. R., Beer, V. et al. (1992). Disseminated 'Mycobacterium genavense' infection in patients with AIDS. Lancet 340, 76-80.
3. Hirschel, B., Chang, H. R., Mach, N., Piguet, P.-F., Cox, J., Piguet, J.-D. et al. (1990). Fatal infection with a novel unindentified Mycobacterium in a man with the acquired immunodeficiency syndrome. New England Journal of Medicine 323, 109-13.
4. Matsiota-Bernard, P., Thierry, D., de Truchis, P., Saillour, M., Paraire, F., Guesdon, J.-L. et al. (1995). Mycobacterium genavense infection in a patient with AIDS who was successfully treated with clarithromycin. Clinical Infectious Diseases 20, 1565-6.
5. Coyle, M. B., Carlson, L. D. C., Wallis, C. K., Leonard, R. B., Raisys, V. A., Kilburn, J. O. et al. (1992). Laboratory aspects of 'Mycobacterium genavense', a proposed species isolated from AIDS patients. Journal of Clinical Microbiology 30, 3206-12.
6. Pechère, M., Opravil, M., Wald, A., Chave, J. P., Bessesen, M., Sievers, A. et al. (1995). Clinical and epidemiologic features of infection with Mycobacterium genavense. Archives of Internal Medicine 155, 400-4.
7. Böttger, E. C. (1994). Mycobacterium genavense: an emerging pathogen. European Journal of Clinical Microbiology and Infectious Diseases 13, 932-6.
8. Cohen, Y., Perronne, C., Lazard, T., Truffot-Pernot, C., Grosset, J., Vildé, J.-L. et al. (1995). Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. Antimicrobial Agents and Chemotherapy 39, 735-8.
9. Perronne, C., Cohen, Y., Truffot-Pernot, C., Grosset, J., Vildé, J.-L. & Pocidalo, J.-J. (1992). Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice. Antimicrobial Agents and Chemotherapy 36, 2408-12.
10. Fernandes, B. P., Hardy, D. J., McDaniel, D., Hanson, C. W. & Swanson, R. N. (1989). In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrobial Agents and Chemotherapy 33, 1531-4.
11. Klemens, S. P., Grossi, M. A. & Cynamon, M. H. (1994). Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex. Antimicrobial Agents and Chemotherapy 38, 234-7.
12. Ji, B., Lounis, N., Truffot-Pernot, C. & Grosset, J. (1994). Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. Antimicrobial Agents and Chemotherapy 38, 2521-9.
13. Lounis, N., Truffot-Pernot, C. & Grosset, J. (1995). Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. Antimicrobial Agents and Chemotherapy 39, 608-12.
14. Cynamon, M. H., Swenson, C. E., Palmer, G. S. & Ginsberg, R. S. (1989). Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrobial Agents and Chemotherapy 33, 1179-83.
15. Inderlied, C. B., Kolonoski, P. T., Wu, M. & Young, L. S. (1989). Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrobial Agents and Chemotherapy 33, 176-80.
16. Lazard, T., Perronne, C., Grosset, J., Vilde, J. L. & Pocidalo, J. J. (1993). Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. Antimicrobial Agents and Chemotherapy 37, 1690-2.
17. Bermudez, L. E., Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L. & Young, L. S. (1996). Activities of bay Y3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Antimicrobial Agents and Chemotherapy 40, 546-51.
18. Craig, W. A. (1998). Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26, 1-10.
19. Furney, S. K., Skinner, P. S., Farrer, J. & Orme, I. M. (1995). Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model. Antimicrobial Agents and Chemotherapy 39, 786-9.
20. Orme, I. M. (1988). Antimycobacterial activity in vivo of LM427 (rifabutin). American Reviews of Respiratory Diseases 138, 1254-7.
21. Inderlied, C. B., Kemper, C. A. & Bermudez, L. E. M. (1993). The Mycobacterium avium complex. Clinical Microbiology Reviews 6, 266-310.